Fabian Kausche
Director/Board Member at SEQUENT SCIENTIFIC LIMITED
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sharat Pandu Rang Narasapur | M | 57 | 7 years | |
| Prasad Lad | M | - | 10 years | |
| Allan Bradley | M | 64 |
PetMedix Ltd.
 PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | 6 years |
| Thomas Weaver | M | - |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | 6 years |
| Kamal Kishore Sharma | M | 76 | 4 years | |
| Rajaram Narayanan | M | 55 | 2 years | |
| Noah Davidsohn | M | - |
Rejuvenate Bio, Inc.
 Rejuvenate Bio, Inc. BiotechnologyHealth Technology Rejuvenate Bio, Inc. operates as a biotechnology company. The company was founded by George Church, Noah Davidsohn and Daniel Oliver is headquartered in San Diego, CA. | - |
| Jolyon Martin | M | 53 |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | 6 years |
| Kausalya Santhanam | M | 56 | 10 years | |
| Matthew Labovitz | M | - |
Bessemer Investors
 Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 2 years |
| Andrew Mendelsohn | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 10 years |
| Daniel Oliver | M | - |
Rejuvenate Bio, Inc.
Rejuvenate Bio, Inc. BiotechnologyHealth Technology Rejuvenate Bio, Inc. operates as a biotechnology company. The company was founded by George Church, Noah Davidsohn and Daniel Oliver is headquartered in San Diego, CA. | - |
| Milind Shripad Sarwate | M | 64 | 4 years | |
| Matthias Manuel Hofer | M | 47 |
Stonehaven Incubate AG
 Stonehaven Incubate AG Financial ConglomeratesFinance Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland. | - |
| Haribabu Bodepudi | M | 60 | 1 years | |
| Ashish Kakabalia | M | - | - | |
| Thomas L. Pajonas | M | 69 |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| Abraham Talmaciu | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| Hamlet Abnousi | M | - |
Novobind Livestock Therapeutics, Inc.
 Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | - |
| Sirjiwan Singh | M | - | 5 years | |
| Gregory Andrews | M | - | 4 years | |
| Samuel Bjork | M | - |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | - |
| Singh Amit | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 7 years |
| Joseph Middleman | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| Kyle Reeves | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| Andy Kleinlein | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 4 years |
| Hamlet Abnousi | M | - |
Novobind Livestock Therapeutics, Inc.
Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | 12 years |
| Saurav Bhala | M | - | 1 years | |
| Bohdan Tyshynsky | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 5 years |
| John Heawood | M | 71 |
The Royal Veterinary College
| 11 years |
| Alastair Kilgour | M | - |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | - |
| Robert Tansley | M | 61 |
PetMedix Ltd.
PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | - |
| Tim Pultorak | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 4 years |
| Cormac G. Kilty | M | 70 |
Stonehaven Incubate AG
Stonehaven Incubate AG Financial ConglomeratesFinance Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland. | - |
| Mark Heffernan | M | 47 |
Stonehaven Incubate AG
Stonehaven Incubate AG Financial ConglomeratesFinance Stonehaven Incubate AG provides investment services in animal health sector. The company is headquartered in Andermatt, Switzerland. | - |
| Leonard Goldberg | M | 61 |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| Daniel J. Simon | M | 55 |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | 12 years |
| Neeraj Bharadwaj | M | 55 | 4 years | |
| Robert Fraser | M | 67 |
Novobind Livestock Therapeutics, Inc.
Novobind Livestock Therapeutics, Inc. BiotechnologyHealth Technology Novobind Livestock Therapeutics, Inc. develops livestock therapeutics. Its molecules specifically target and neutralize multiple virulence factors necessary for the survival, infection, and proliferation of Salmonella in the GI. The company is headquartered in Vancouver, Canada. | - |
| David Barr | M | 60 |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| David Laurence George Danson | M | 79 |
The Royal Veterinary College
| - |
| Glenn M. Fischer | M | 73 |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
| Gabriel Trank | M | - |
Bessemer Investors
Bessemer Investors Investment ManagersFinance Bessemer Investors (Bessemer Investors) is a private equity firm founded in 2018. The firm is headquartered in New York. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tushar Pravinchandra Mistry | M | - | 5 years | |
| Krunal Shah | M | - | 5 years | |
| Aaron Michel | M | - |
Harvard Business School
| 3 years |
| Manish Gupta | M | - | 8 years | |
| Alex Sloane | M | - |
Harvard Business School
| 10 years |
| Desiree Ralls-Morrison | F | 57 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 4 years |
| Wendy Hufford | F | 62 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | 3 years |
| Trevor Magyar | M | - |
Harvard Business School
| 2 years |
| Lea Bajc | F | - |
Harvard Business School
| 2 years |
| Teo Vujcic | M | - |
Harvard Business School
| 2 years |
| Tomasz Artur Danis | M | 45 |
Harvard Business School
| 2 years |
| Ivana Budin Arhanic | F | - |
Harvard Business School
| 2 years |
| José Francisco Hintze | M | 73 |
Pfizer Animal Health
 Pfizer Animal Health Pharmaceuticals: MajorHealth Technology Part of Zoetis, Inc., Pfizer Animal Health engages in discovery, development and manufacture of innovative animal vaccines and medicines. The company is based in São Paulo, Brazil. | 29 years |
| Giulio William Pizzini | M | 50 |
Harvard Business School
| 2 years |
| Katina Todorova Stefanova | F | - |
Harvard Business School
| 2 years |
| Ivan M. Møller | M | 52 |
Harvard Business School
| 2 years |
| Vanessa Ann Bartram | F | - |
Harvard Business School
| 2 years |
| Christopher Anthony Scovotti | M | - |
Harvard Business School
| 2 years |
| Marc Herdegen | M | - |
Harvard Business School
| 2 years |
| Leslie Feinzaig | F | - |
Harvard Business School
| 2 years |
| Alexis DePree | F | 45 |
Harvard Business School
| 2 years |
| Sunaina Haldea | F | 43 |
Harvard Business School
| 2 years |
| Ali Khanbhai | M | 49 |
Harvard Business School
| 2 years |
| Hector Gil | M | - |
Harvard Business School
| 2 years |
| Kathryn J Jackson | F | - |
Harvard Business School
| 2 years |
| Marcus Osborne | M | - |
Harvard Business School
| 2 years |
| Ami Mehta | F | - |
Harvard Business School
| 2 years |
| Oliver Thomas | M | 44 |
Harvard Business School
| 2 years |
| Carlos Miguel Galvez | M | - |
Harvard Business School
| 2 years |
| Daniel Penn | M | - |
Harvard Business School
| 2 years |
| Ryan Miller | M | - |
Harvard Business School
| 2 years |
| Fernando Vigil | M | - |
Harvard Business School
| 2 years |
| Rob W. Reistetter | M | - |
Harvard Business School
| 2 years |
| Jesse Feldman | M | 47 |
Harvard Business School
| 2 years |
| David Travers | M | 47 |
Harvard Business School
| 2 years |
| Robb LeMasters | M | 46 |
Harvard Business School
| 2 years |
| Pierre O. Py | M | - |
Harvard Business School
| 2 years |
| Tarim Wasim | M | 46 |
Harvard Business School
| 2 years |
| Robert Go | M | - |
Harvard Business School
| 2 years |
| Alexander Samwer | M | 49 |
Harvard Business School
| 2 years |
| Mac Grayson | M | - |
Harvard Business School
| 2 years |
| Thomas Patrick Karthaus | M | - |
Harvard Business School
| 2 years |
| Jeffrey Liaw | M | 47 |
Harvard Business School
| 2 years |
| David Salanic | M | - |
Harvard Business School
| 2 years |
| Jeremy A. Lynch | M | - |
Harvard Business School
| 2 years |
| Edward Sobol | M | - |
Harvard Business School
| 2 years |
| Ruben Kliksberg | M | - |
Harvard Business School
| 2 years |
| Maneesh Modi | M | - |
Harvard Business School
| 2 years |
| Firas Abi-Nassif | M | - |
Harvard Business School
| 2 years |
| Tomas Ackerman | M | 44 |
Harvard Business School
| 2 years |
| Laura Grattan | F | 42 |
Harvard Business School
| 2 years |
| Ruy Kameyama | M | 46 |
Harvard Business School
| 1 years |
| Tomas Diaz Mathe | M | - |
Harvard Business School
| 2 years |
| John Doran | M | 45 |
Harvard Business School
| 2 years |
| Miraj D. Patel | M | - |
Harvard Business School
| 2 years |
| Robert Myers | M | - |
Harvard Business School
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 69 | 69.70% |
| India | 15 | 15.15% |
| United Kingdom | 8 | 8.08% |
| Canada | 3 | 3.03% |
| Switzerland | 3 | 3.03% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fabian Kausche
- Personal Network
